Document is current
Any future updates will be listed below
-
Authors
Mikkelsen, Vilde Elisabeth
Stensjøen, Anne Line
Granli, Unn Sophie
Berntsen, Erik Magnus
Salvesen, Øyvind
Solheim, Ole
Torp, Sverre Helge
-
Funding
Funding for this research was provided by:
Norges Teknisk-Naturvitenskapelige Universitet (NO)
Norges Teknisk-Naturvitenskapelige Universitet
National Competence Centre for Ultrasound and Image Guided Therapy
Norwegian National Advisory Unit on Functional MRI Methods
Central Norwegian Brain Tumor Registry
- License Information
-
More Information
Article History
Received: 19 December 2017
Accepted: 22 August 2018
First Online: 3 September 2018
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Committee (Central) as part of a larger project (references 2011/974 and 2013/1348) and adhered with the Declaration of Helsinki. Most patients had provided written informed consent to be included in a related glioma outcome study (reference 2011/974). The regional ethics committee waived informed consent for retrospective evaluation of patient data for the remaining patients, and did not require obtained written informed consent from a relative/guardian.
: Not applicable.
: O.S. has previously been an unpaid member of a national advisory committee on treatment guidelines for brain tumors. All other authors disclose no potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
